FindTrial
Sign In

Mannose-binding lectin (MBL) and post-operative complications/bypass patency with arterial operations

Mannose-binding lectin (MBL) and post-operative complications/bypass patency with arterial operations - MBL and Bypass patency

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON37369
Enrollment
2000
Registered
2012-06-05
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mannose-binding lectin genotype Post-operative complications

Interventions

None listed

Sponsors

Atrium Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with an arterial operation, whereby we will differentiate between femoral and crural.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
The outcome were we will be particularly focus on are the genotype of MBL. Next to this are the post-operative complications (wound infections, re-operations, amputations etc.) correlated.—

Secondary

MeasureTime frame
Possible secundair outcomes values are, recovery measured in time and eventually longer term comlications.—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)